Paul Spangler

Paul Spangler

Auto-generated profile, based on publicly available information

Paul Spangler

University Medical Center

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
JRJudith Rees
Judith Rees
AWAnnika Winkler
Annika Winkler
JHJudith Huettemeister
Judith Huettemeister
LSLaura Stengel
Laura Stengel
PSPaul Spangler
Paul Spangler
NHNiklas Hegemann
Niklas Hegemann
This study evaluates rostafuroxin, a selective ouabain inhibitor, for its potential to antagonize electrophysiological derangements in ouabain overdosing. Methodologically, the study uses the iCE model, previously introduced as a suitable 3 R-compliant cardiovascular research platform. We developed and validated a comprehensive electrophysiological workflow in iCEs to perform our investigations. Ouabain increased heart rate variability, induced arrhythmia and electrolyte imbalances in iCEs, whereas rostafuroxin largely protected them from these effects.